EYPT vs. TRNS

Last updated Jun 4, 2026

EYPT (Eyepoint Pharmaceuticals Inc) and TRNS (Transcat, Inc.) are both stocks. EYPT operates in Biotechnology (Healthcare), while TRNS operates in Industrial Distribution (Industrials). Over the past 10 years, EYPT returned -9.93%/yr vs 24.18%/yr for TRNS. At a 0.10 correlation, their price movements are largely independent.

Performance

EYPT vs. TRNS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eyepoint Pharmaceuticals Inc (EYPT) and Transcat, Inc. (TRNS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, EYPT achieves a -32.46% return, which is significantly lower than TRNS's 59.00% return. Over the past 10 years, EYPT has underperformed TRNS with an annualized return of -9.93%, while TRNS has yielded a comparatively higher 24.18% annualized return.

EYPT

• 1D: -1.52%
• 1M: -10.90%
• YTD: -32.46%
• 6M: -15.01%
• 1Y: 51.97%
• 3Y*: 27.31%
• 5Y*: 6.14%
• 10Y*: -9.93%

TRNS

• 1D: -0.40%
• 1M: 27.82%
• YTD: 59.00%
• 6M: 63.23%
• 1Y: 4.94%
• 3Y*: 0.76%
• 5Y*: 10.04%
• 10Y*: 24.18%

*Multi-year figures are annualized to reflect compound growth (CAGR)

EYPT vs. TRNS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
EYPT Eyepoint Pharmaceuticals Inc	-32.46%	145.23%	-67.76%	560.29%	-71.41%	86.02%	-57.55%	-17.99%	75.00%	-36.84%
TRNS Transcat, Inc.	59.00%	-46.35%	-3.28%	54.27%	-23.33%	166.52%	8.85%	67.51%	33.47%	31.94%

Correlation

The correlation between EYPT and TRNS is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.18
Correlation (10Y) Calculated over the trailing 10-year period	0.15
Correlation (All Time) Calculated using the full available price history since Jan 28, 2005	0.10

The correlation between EYPT and TRNS shifts across timeframes, from 0.05 (1 year) to 0.18 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS EYPT : -$3.12 TRNS : $0.58
PS Ratio EYPT : 29.25 TRNS : 2.54
Total Revenue (TTM) EYPT : $31.37M TRNS : $331.88M
Gross Profit (TTM) EYPT : $29.31M TRNS : $108.40M
EBITDA (TTM) EYPT : -$239.53M TRNS : $33.66M

Return for Risk

EYPT vs. TRNS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EYPT

EYPT Risk / Return Rank: 66
EYPT Sharpe Ratio Rank: 66
EYPT Sortino Ratio Rank: 67
EYPT Omega Ratio Rank: 64
EYPT Calmar Ratio Rank: 67
EYPT Martin Ratio Rank: 66

TRNS

TRNS Risk / Return Rank: 42
TRNS Sharpe Ratio Rank: 44
TRNS Sortino Ratio Rank: 42
TRNS Omega Ratio Rank: 41
TRNS Calmar Ratio Rank: 43
TRNS Martin Ratio Rank: 43

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EYPT vs. TRNS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eyepoint Pharmaceuticals Inc (EYPT) and Transcat, Inc. (TRNS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	EYPT	TRNS	Difference
Sharpe ratio: Return per unit of total volatility	0.78	0.10	+0.68
Sortino ratio: Return per unit of downside risk	1.54	0.50	+1.05
Omega ratio: Gain probability vs. loss probability	1.18	1.06	+0.12
Calmar ratio: Return relative to maximum drawdown	1.38	0.12	+1.26
Martin ratio: Return relative to average drawdown	2.96	0.22	+2.74
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

EYPT vs. TRNS - Sharpe Ratio Comparison

The current EYPT Sharpe Ratio is 0.78, which is higher than the TRNS Sharpe Ratio of 0.10. The chart below compares the historical Sharpe Ratios of EYPT and TRNS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	EYPT	TRNS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.78	0.10	+0.68
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.05	0.23	-0.18
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.10	0.57	-0.67
Sharpe Ratio (All Time) Calculated using the full available price history	-0.09	0.17	-0.26

Drawdowns

EYPT vs. TRNS - Drawdown Comparison

The maximum EYPT drawdown since its inception was -97.73%, roughly equal to the maximum TRNS drawdown of -93.42%. Use the drawdown chart below to compare losses from any high point for EYPT and TRNS.

Drawdown Indicators

	EYPT	TRNS	Difference
Max Drawdown Largest peak-to-trough decline	-97.73%	-93.42%	-4.31%
Max Drawdown (1Y) Largest decline over 1 year	-37.93%	-42.92%	+4.99%
Max Drawdown (3Y) Largest decline over 3 years	-86.10%	-63.86%	-22.24%
Max Drawdown (5Y) Largest decline over 5 years	-87.61%	-63.86%	-23.75%
Max Drawdown (10Y) Largest decline over 10 years	-94.45%	-63.86%	-30.59%
Current Drawdown Current decline from peak	-87.71%	-37.39%	-50.32%
Average Drawdown Average peak-to-trough decline	-76.41%	-35.38%	-41.03%
Ulcer Index Depth and duration of drawdowns from previous peaks	17.60%	22.35%	-4.75%

Volatility

EYPT vs. TRNS - Volatility Comparison

The current volatility for Eyepoint Pharmaceuticals Inc (EYPT) is 14.28%, while Transcat, Inc. (TRNS) has a volatility of 18.16%. This indicates that EYPT experiences smaller price fluctuations and is considered to be less risky than TRNS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	EYPT	TRNS	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.28%	18.16%	-3.88%
Volatility (6M) Calculated over the trailing 6-month period	45.65%	35.36%	+10.29%
Volatility (1Y) Calculated over the trailing 1-year period	67.49%	47.62%	+19.87%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	118.34%	43.36%	+74.98%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	100.38%	42.39%	+57.99%

Dividends

EYPT vs. TRNS - Dividend Comparison

Neither EYPT nor TRNS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both EYPT and TRNS in my portfolio?

EYPT and TRNS have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, EYPT or TRNS?

TRNS has higher volatility (18.16%) compared to EYPT (14.28%). In terms of maximum drawdown, EYPT dropped -97.73% vs TRNS's -93.42%.

Which has better risk-adjusted returns?

EYPT currently has the higher Sharpe Ratio (0.78 vs 0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.